{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:51:06Z","timestamp":1752231066741},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:00:00Z","timestamp":1431388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12888-015-0486-x","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T08:39:28Z","timestamp":1431333568000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Case report: low-titre anti-Yo reactivity in a female patient with psychotic syndrome and frontoparieto-cerebellar atrophy"],"prefix":"10.1186","volume":"15","author":[{"given":"Dominique","family":"Endres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeniy","family":"Perlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Stich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp Tobias","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"L\u00fctzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludger","family":"Tebartz van Elst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,12]]},"reference":[{"key":"486_CR1","unstructured":"Friese MA MT, editor. Antik\u00f6rper-assoziierte autoimmune Enzephalopathien: Therapie und Verlauf neurologischer Erkrankungen. 6th ed. Stuttgart: Kohlhammer."},{"key":"486_CR2","unstructured":"Bien C. Immunvermittelte Erkrankungen der grauen ZNS-Substanz sowie Neurosarkoidose: http:\/\/www.dgn.org\/leitlinien-online-2012\/inhalte-nach-kapitel\/2396-ll-32-2012-immunvermittelte-erkrankungen-der-grauen-zns-substanz-sowie-neurosarkoidose.html. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie 2012."},{"issue":"5","key":"486_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.4088\/JCP.10l06510","volume":"72","author":"LT van Elst","year":"2011","unstructured":"van Elst LT, Kl\u00f6ppel S, Rauer S. Voltage-gated potassium channel\/LGI1 antibody-associated encephalopathy may cause brief psychotic disorder. J Clin Psychiatry. 2011;72(5):722\u20133.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"486_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1212\/CPJ.0b013e31826af23e","volume":"2","author":"MR Rosenfeld","year":"2012","unstructured":"Rosenfeld MR, Titulaer MJ, Dalmau J. Paraneoplastic syndromes and autoimmune encephalitis: Five new things. Neurol Clin Pract. 2012;2(3):215\u201323.","journal-title":"Neurol Clin Pract"},{"key":"486_CR5","first-page":"725936","volume":"2013","author":"L Hasadsri","year":"2013","unstructured":"Hasadsri L, Lee J, Wang BH, Yekkirala L, Wang M. Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung. Case Rep Neurol Med. 2013;2013:725936.","journal-title":"Case Rep Neurol Med"},{"issue":"10","key":"486_CR6","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","volume":"42","author":"K Peterson","year":"1992","unstructured":"Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology. 1992;42(10):1931\u20137.","journal-title":"Neurology"},{"issue":"9","key":"486_CR7","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1002\/pon.3270","volume":"22","author":"RG Key","year":"2013","unstructured":"Key RG, Root JC. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review. Psychooncology. 2013;22(9):2152\u20135.","journal-title":"Psychooncology"},{"issue":"4","key":"486_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00115-014-4030-x","volume":"85","author":"O Stich","year":"2014","unstructured":"Stich O, Rauer S. Paraneoplastische neurologische Syndrome und Autoimmunenzephalitiden. Nervenarzt. 2014;85(4):485\u201398. quiz 499-501.","journal-title":"Nervenarzt"},{"issue":"12","key":"486_CR9","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1515\/CCLM.2008.354","volume":"46","author":"O Stich","year":"2008","unstructured":"Stich O, Jarius S, Rasiah C, Voltz R, Rauer S. Recombinant immunoblot for assessment of intrathecally synthesised paraneoplastic antineuronal antibodies in cerebrospinal fluid from patients with paraneoplastic neurological syndromes. Clin Chem Lab Med. 2008;46(12):1793\u20135.","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"486_CR10","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatr. 2004;75(8):1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"3","key":"486_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1176\/jnp.16.3.367","volume":"16","author":"JD Schmahmann","year":"2004","unstructured":"Schmahmann JD. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci. 2004;16(3):367\u201378.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"486_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/14734220701490995","volume":"6","author":"JD Schmahmann","year":"2007","unstructured":"Schmahmann JD, Weilburg JB, Sherman JC. The neuropsychiatry of the cerebellum - insights from the clinic. Cerebellum. 2007;6(3):254\u201367.","journal-title":"Cerebellum"},{"issue":"4","key":"486_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1524-4741.2008.00604.x","volume":"14","author":"S Ogita","year":"2008","unstructured":"Ogita S, Llaguna OH, Feldman SM, Blum R. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2\/neu overexpressing breast cancer: a case report with a current literature review. Breast J. 2008;14(4):382\u20134.","journal-title":"Breast J"},{"key":"486_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S1353-8020(08)70027-0","volume":"13 Suppl 3","author":"PM Wadia","year":"2007","unstructured":"Wadia PM, Lang AE. The many faces of corticobasal degeneration. Parkinsonism Relat Disord. 2007;13 Suppl 3:336\u201340.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"486_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0303-8467(01)00114-7","volume":"103","author":"M Goethals","year":"2001","unstructured":"Goethals M, Santens P. Posterior cortical atrophy. Two case reports and a review of the literature. Clin Neurol Neurosurg. 2001;103(2):115\u20139.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"486_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1176\/appi.neuropsych.13070153","volume":"27","author":"L Laadhar","year":"2015","unstructured":"Laadhar L, Sidhom O, Zitouni M, Sassi N, Abdelghaffar W, Lahmar H, et al. High prevalence of antineuronal antibodies in tunisian psychiatric inpatients. J Neuropsychiatry Clin Neurosci. 2015;27(1):54\u20138.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"9","key":"486_CR17","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1176\/appi.ajp.2010.09101547","volume":"167","author":"MS Kayser","year":"2010","unstructured":"Kayser MS, Kohler CG, Dalmau J. Psychiatric manifestations of paraneoplastic disorders. Am J Psychiatry. 2010;167(9):1039\u201350.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"486_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","volume":"70","author":"J Steiner","year":"2013","unstructured":"Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein H, Vielhaber S, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry. 2013;70(3):271\u20138.","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"486_CR19","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/mp.2013.110","volume":"19","author":"C Hammer","year":"2014","unstructured":"Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M, et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry. 2014;19(10):1143\u20139.","journal-title":"Mol Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-015-0486-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-015-0486-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-015-0486-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-015-0486-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T12:59:43Z","timestamp":1630587583000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-015-0486-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,12]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["486"],"URL":"https:\/\/doi.org\/10.1186\/s12888-015-0486-x","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,12]]},"assertion":[{"value":"2 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"112"}}